Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NCL
NCL logo

NCL Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.157
Open
0.157
VWAP
0.16
Vol
7.12K
Mkt Cap
3.42M
Low
0.157
Amount
1.12K
EV/EBITDA(TTM)
--
Total Shares
22.74M
EV
7.59M
EV/OCF(TTM)
--
P/S(TTM)
0.13
Northann Corp. is a technology innovator and producer of natural and sustainable material-based products for interior finishes. The Company specializes in additive manufacturing and three-dimensional (3D) printing technologies for the building materials industry. Its portfolio of manufacturing solutions relies upon the use of ink, coating, resin, sound padding, glue and other raw materials to create a wide variety of flooring, decking and other products for customers throughout North America, Europe and other regions under the brand name Benchwick. Through its flagship brand, Benchwick, the Company provides flooring, decking, and other construction products. Its brands include Benchwick, SuperOak, and Dotfloor. Its Benchwick 3D Printing ecosystem offers flooring and wall solutions backed by its own proprietary intellectual properties. This advanced platform integrates patented 3D printing technology to create customizable and sustainable products.
Show More

Events Timeline

(ET)
2025-12-23
11:50:00
Northann Corp Trading Resumes
select
2025-12-23
10:50:00
Northann Corp Trading Halted, News Pending
select
2025-12-11 (ET)
2025-12-11
16:30:00
Northann Receives NYSE Warning for Non-Compliance with Listing Standards
select

News

moomoo
4.5
03-02moomoo
NORTHANN CORP. CONFIRMS NYSE AMERICAN'S APPROVAL OF ITS STRATEGIC LISTING OPTIMIZATION PLAN
  • Announcement of Acceptance: Northann Corp. has announced that it has accepted its strategic listing optimization plan.
  • Focus on Strategic Growth: The acceptance of this plan indicates a commitment to enhancing the company's strategic positioning and growth potential.
Globenewswire
4.5
01-02Globenewswire
Northann Corp. Expands into Major North American Retail Market in 2026
  • Strategic Endorsement: Northann Corp. received strong support from shareholders during the Annual General Meeting on December 31, 2025, indicating trust and willingness for collaboration in the company's future development.
  • Market Expansion: The company's core product lines are set to enter one of the largest retail conglomerates in North America in 2026, which will significantly enhance brand visibility and expand market share.
  • Institutional Maturity: CEO Lin Li stated that 2026 marks a pivotal milestone for the company, leveraging its institutional maturity to drive the widespread adoption of its disruptive surface solutions through partnerships with tier-1 retailers.
  • Innovation Commitment: Since its founding in 2022, Northann Corp. has secured over 60 patents, showcasing its commitment to innovation and sustainability in the building materials industry, and will continue to drive technological advancements in the sector.
Benzinga
8.5
2025-12-31Benzinga
FuelCell Energy Files for $200 Million Stock Offering, Shares Drop 8.9%
  • Stock Offering: FuelCell Energy announced an amended sales agreement to increase the total amount of shares available for sale to $200 million, which led to an 8.9% drop in share price to $7.23 on Wednesday, indicating a negative market reaction to the dilution of shares.
  • Market Reaction: The announcement of the stock offering raised investor concerns, as the significant drop in share price could impact the company's future fundraising capabilities and market confidence, particularly in the current economic climate where investors are sensitive to equity dilution.
  • Funding Purpose: FuelCell Energy plans to use the proceeds from this offering to support its R&D and operational expenditures, and while the stock faces short-term pressure, successful fundraising could provide the necessary capital to drive technological innovation and market expansion in the long run.
  • Industry Impact: In the context of increasing competition in the hydrogen and fuel cell industry, FuelCell Energy's stock offering may affect its reputation among investors, especially as the effectiveness of its financing strategy will directly influence its market position compared to other competitors.
Benzinga
4.0
2025-12-31Benzinga
U.S. Initial Jobless Claims Drop to 199,000, Beating Estimates
  • Jobless Claims Decline: Initial jobless claims fell by 16,000 to 199,000 for the week ending December 27, significantly below market expectations of 220,000, indicating resilience in the labor market and potentially boosting investor confidence.
  • Tech Sector Gains: Information technology shares rose by 0.2% on Wednesday, demonstrating relative strength amid overall market declines, which may attract more capital inflows into the sector.
  • Real Estate Sector Decline: Real estate stocks fell by 0.3% on Wednesday, reflecting cautious sentiment regarding the sector's outlook, which could negatively impact related companies' stock performance.
  • Mixed International Markets: Asian markets closed mixed, with Hong Kong's Hang Seng Index down 0.87% while China's Shanghai Composite gained 0.09%, indicating regional economic uncertainty that may influence global investor decisions.
Benzinga
5.0
2025-12-31Benzinga
Vanda Pharmaceuticals' NEREUS Receives FDA Approval, Shares Surge 17.5%
  • FDA Approval: Vanda Pharmaceuticals' NEREUS (tradipitant) has received FDA approval for the prevention of motion-induced vomiting in adults, marking a significant advancement in the company's neuropharmaceutical portfolio and is expected to drive future sales growth.
  • Stock Surge: Following the FDA approval announcement, Vanda's shares jumped 17.5% to $8.26 in pre-market trading, reflecting strong market confidence in the new drug's potential and likely attracting increased investor interest.
  • Market Outlook: The approval of NEREUS not only opens new market opportunities for Vanda Pharmaceuticals but also enhances its market share in the competitive antiemetic drug sector, strengthening the company's long-term profitability prospects.
  • Investor Confidence: This FDA approval boosts investor expectations for Vanda's future performance, potentially prompting more institutional investors to reassess their portfolios, further driving the stock price upward.
Benzinga
9.0
2025-12-29Benzinga
Ultragenyx Shares Plunge 42% Following Phase 3 Study Failures for Setrusumab
  • Stock Plunge: Ultragenyx Pharmaceutical's shares fell sharply by 42% to $19.84 on Monday, primarily due to the failure of its Phase 3 Orbit and Cosmic studies for setrusumab (UX143) in Osteogenesis Imperfecta, leading to a significant decline in market confidence.
  • Clinical Trial Failure: The results from Mereo BioPharma and Ultragenyx indicated that setrusumab did not achieve statistical significance in reducing the annualized clinical fracture rate, which not only impacts the company's short-term financial performance but may also have long-term negative implications for its future R&D investments and market competitiveness.
  • Severe Market Reaction: The disappointing trial results raised investor concerns about Ultragenyx's future prospects, resulting in a substantial decrease in its market capitalization, reflecting the high sensitivity of investors to the success or failure of clinical trials in the biopharmaceutical sector.
  • Industry Impact: Ultragenyx's failure could have a ripple effect across the biopharmaceutical industry, particularly in the bone metabolism disease space, as investors may adopt a more cautious approach towards similar product developments, potentially affecting financing and R&D strategies of related companies.
Wall Street analysts forecast NCL stock price to rise
1 Analyst Rating
Wall Street analysts forecast NCL stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
0.97
Averages
0.97
High
0.97
Current: 0.000
sliders
Low
0.97
Averages
0.97
High
0.97
No data

No data

Valuation Metrics

The current forward P/E ratio for Northann Corp (NCL.A) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Northann Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks under 2$
Intellectia · 732 candidates
Price: $0.00 - $2.00List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
TIRX logo
TIRX
Tian Ruixiang Holdings Ltd
6.37M
STFS logo
STFS
Star Fashion Culture Holdings Ltd
4.80M
PTLE logo
PTLE
PTL Ltd
10.47M
CENN logo
CENN
Cenntro Inc (The Corporation)
11.05M
JTAI logo
JTAI
Jet.AI Inc
4.96M
WCT logo
WCT
Wellchange Holdings Co Ltd
20.03M
Stocks under 1 dollar
Intellectia · 291 candidates
Price: $0.00 - $1.00List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
MTEN logo
MTEN
Mingteng International Corp Inc
4.13M
ATPC logo
ATPC
Agape ATP Corp
3.93M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
10.96M
APLT logo
APLT
Applied Therapeutics Inc
15.14M
MKDW logo
MKDW
MKDWELL Tech Inc
12.07M
PTLE logo
PTLE
PTL Ltd
11.70M
Can you recommend stocks under $0.01?
Intellectia · 28 candidates
Price: <= $0.20
Ticker
Name
Market Cap$
top bottom
BURU logo
BURU
NUBURU Inc
77.15M
GSIW logo
GSIW
Garden Stage Ltd
31.74M
SAFX logo
SAFX
XCF Global Inc
28.75M
WCT logo
WCT
Wellchange Holdings Co Ltd
22.89M
ZJYL logo
ZJYL
Jin Medical International Ltd
19.82M
APLT logo
APLT
Applied Therapeutics Inc
14.63M

Whales Holding NCL

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Northann Corp (NCL) stock price today?

The current price of NCL is 0.157 USD — it has increased 4.65

What is Northann Corp (NCL)'s business?

Northann Corp. is a technology innovator and producer of natural and sustainable material-based products for interior finishes. The Company specializes in additive manufacturing and three-dimensional (3D) printing technologies for the building materials industry. Its portfolio of manufacturing solutions relies upon the use of ink, coating, resin, sound padding, glue and other raw materials to create a wide variety of flooring, decking and other products for customers throughout North America, Europe and other regions under the brand name Benchwick. Through its flagship brand, Benchwick, the Company provides flooring, decking, and other construction products. Its brands include Benchwick, SuperOak, and Dotfloor. Its Benchwick 3D Printing ecosystem offers flooring and wall solutions backed by its own proprietary intellectual properties. This advanced platform integrates patented 3D printing technology to create customizable and sustainable products.

What is the price predicton of NCL Stock?

Wall Street analysts forecast NCL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NCL is0.97 USD with a low forecast of 0.97 USD and a high forecast of 0.97 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Northann Corp (NCL)'s revenue for the last quarter?

Northann Corp revenue for the last quarter amounts to 3.54M USD, increased 38.62

What is Northann Corp (NCL)'s earnings per share (EPS) for the last quarter?

Northann Corp. EPS for the last quarter amounts to -0.57 USD, decreased -456.25

How many employees does Northann Corp (NCL). have?

Northann Corp (NCL) has 49 emplpoyees as of March 21 2026.

What is Northann Corp (NCL) market cap?

Today NCL has the market capitalization of 3.42M USD.